Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid – Results from the ToFingo Successor Study
Von Lohmann L et al, erschienen in „Frontiers in Immunology“ (Vol. 9, Juli 2018)